News May 19, 2022 Kodiak Sciences inaugurates its purpose-built bioconjugation facility in Visp To support potential commercial manufacture of its KSI-301 candidate, Kodiak Sciences has launched a purpose-built bioconjugation facility in Lon...
News May 18, 2022 Cell and gene therapy specialist Cytiva opens new facility in Grens Global life sciences leader Cytiva is opening a new manufacturing in Grens, which will also house the company’s Center of Excellence for cell and...
News May 18, 2022 Aesara heading to the Greater Zurich Area Aesara is establishing a new branch office in the Greater Zurich Area this May. The North American market access agency sees becoming a part of t...
News May 11, 2022 Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device In collaboration with Limula, Valais-based CEIDOS has received a grant of EUR 1.14 million from Eurostars to develop a platform dedicated to the ...
News May 10, 2022 Michael J. Fox Foundation awards Asceneuron a grant to treat Parkinson’s disease Committed to accelerating research into novel Parkinson’s Disease therapies, The Michael J. Fox Foundation for Parkinson’s Research is again awar...
News May 04, 2022 Researchers from Bern unveil a painless and reliable allergy test Researchers at the University of Bern and Inselspital, Bern University Hospital, have developed a novel test that massively simplifies the diagno...
News May 04, 2022 Engimmune Therapeutics banks 15.5 million Swiss francs Engimmune Therapeutics will now be in a position to drive forward its innovative platforms for the development of T-cell therapies against cancer...
News May 03, 2022 New record set for biotech investments The Swiss biotech sector benefitted from investments totaling 3.33 billion Swiss francs overall in 2021. A record level of 2.56 billion Swiss fra...
News May 03, 2022 Why Switzerland’s pioneering role in blockchain combined with its biotech heritage makes it a source of innovation With the rise of new technologies such as blockchain and AI, the pragmatic regulatory approach of the Swiss authorities has become an important a...
News May 02, 2022 Bionter receives 3 million US dollars in investments Bionter AG has received 3 million US dollars in a seed funding round. These funds will enable Bionter to bring to market its technology for count...
News Apr 26, 2022 Vaud-based cell imaging specialist Nanolive raises USD 20 million A leader in the field of live cell imaging and analysis, Nanolive has successfully completed its first financing round in the amount of USD 20 mi...
News Apr 19, 2022 CDR-Life receives 76 million US dollars The biotech company CDR-Life has concluded a series A funding round with 76 million US dollars. This is intended to be used for further developme...
News Mar 17, 2022 Ginkgo Bioworks to acquire Basel-based firm FGen AG The US biotechnology firm Ginkgo Bioworks has agreed a takeover deal for the start-up FGen. The Basel-based firm develops technologies for progra...
News Mar 15, 2022 Leman Biotech raises USD 11 million for its immunotherapy boosting protein EPFL spin-off Leman Biotech has raised USD 11 million for its protein that can improve the effectiveness of immunotherapy drugs used to treat som...
News Mar 10, 2022 Park Innovaare pioneer LeadXpro to move into new premises The first member firm of Park Innovaare in Villigen in the canton of Aargau, leadXpro, will move into new premises there in 2024. These are locat...
News Mar 08, 2022 BioArk Monthey’s technology site expands Following a first expansion in 2015, the technology site specialized in life sciences, BioArk Monthey, grows once more with the addition of a thi...
News Mar 02, 2022 Single-cell technology specialist SEED Biosciences receives FIT boost Through a Tech Growth loan of CHF 400’000, the FIT will fund SEED Biosciences’ sales distribution network expansion in the US to partner with mar...
News Mar 02, 2022 Vaccines unique to each patient and cancer are being tested at the CHUV Two clinical trials on anti-cancer vaccines have just started at the Lausanne University Hospital (CHUV). Their groundbreaking nature could revol...